In 2002, Offterdinger et al. observed full-length nuclear HER3 in human breast cancer MTSV1-7 cells [28], which was validated by Koumakpayi et al. in multiple prostate cancer cell lines [29]. This evidence concerns the gene ERBB3 and breast carcinoma.